New psychoactive substances: a review and updates

A Shafi, AJ Berry, H Sumnall… - Therapeutic …, 2020 - journals.sagepub.com
New psychoactive substances (NPS) are a heterogeneous group of substances. They are
associated with a number of health and social harms on an individual and societal level …

Designer drugs: mechanism of action and adverse effects

D Luethi, ME Liechti - Archives of toxicology, 2020 - Springer
Psychoactive substances with chemical structures or pharmacological profiles that are
similar to traditional drugs of abuse continue to emerge on the recreational drug market …

A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment

RJ Tait, D Caldicott, D Mountain, SL Hill… - Clinical …, 2016 - Taylor & Francis
Abstract Context: Synthetic cannabinoids (SCs) such as “Spice”,“K2”, etc. are widely
available via the internet despite increasing legal restrictions. Currently, the prevalence of …

[PDF][PDF] Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs

SMR Gurney, KS Scott, SL Kacinko, BC Presley… - Forensic Sci …, 2014 - chm.uri.edu
Synthetic cannabinoid drugs have become an established part of the recreational drug
landscape in the United States and internationally. These drugs are manufactured in …

Spicing things up: synthetic cannabinoids

M Spaderna, PH Addy, DC D'Souza - Psychopharmacology, 2013 - Springer
Rationale Recently, products containing synthetic cannabinoids, collectively referred to as
Spice, are increasingly being used recreationally. Objectives The availability, acute …

Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample

AR Winstock, MJ Barratt - Drug and alcohol dependence, 2013 - Elsevier
BACKGROUND: The last decade has seen the appearance of myriad novel psychoactive
substances with diverse effect profiles. Synthetic cannabinoids are among the most recently …

The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects

J Van Amsterdam, T Brunt… - Journal of …, 2015 - journals.sagepub.com
Cannabis use is associated with an increased risk of psychosis in vulnerable individuals.
Cannabis containing high levels of the partial cannabinoid receptor subtype 1 (CB1) agonist …

Synthetic cannabinoids—further evidence supporting the relationship between cannabinoids and psychosis

L Fattore - Biological psychiatry, 2016 - Elsevier
Consumption of synthetic mind-altering compounds, also known as “new psychoactive
substances,” is increasing globally at an alarming rate. Synthetic cannabinoids (SCs) are …

Post-mortem toxicology: a systematic review of death cases involving synthetic cannabinoid receptor agonists

A Giorgetti, FP Busardò, R Tittarelli, V Auwärter… - Frontiers in …, 2020 - frontiersin.org
Background Synthetic cannabinoid receptor agonists (SCRAs) have become the largest
group of new psychoactive substances monitored by the European Union Early Warning …

“Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report

D Papanti, F Schifano, G Botteon… - Human …, 2013 - Wiley Online Library
Objectives The use of synthetic cannabimimetics (SC;“spice” drugs) is increasing, especially
among teenagers and young adults. In parallel with this, the number of studies describing …